Valuation: Monto Minerals Ltd

Market Cap 81.89M 57.82M 50.11M 46.91M 42.8M 80.54M 5.51B 550M 215M 2.76B 217M 212M 9.21B P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 81.87M 57.8M 50.09M 46.89M 42.79M 80.52M 5.51B 550M 215M 2.76B 217M 212M 9.21B EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 16/01/1994
Chief Executive Officer - 10/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 20/10/2025
Director/Board Member - 20/10/2025
Chairman - 25/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%+11.67%-14.58%+21.88% 38.43B
-0.36%+0.85%-40.08%+160.95% 13.45B
+0.55%+2.09%-21.39%+70.34% 5.49B
+0.65%+8.28%-1.50% - 2.55B
-3.06%-0.07% - - 1.83B
-1.21%-0.78%+19.56%-44.53% 1.68B
-3.85%-4.28%-36.56% - 1.04B
+1.74%+5.66%+39.40%+128.92% 923M
-0.27%-0.54%-33.09%-45.40% 845M
Average -0.56%+91.66%-11.03%+48.69% 7.36B
Weighted average by Cap. +0.31%+193.54%-18.90%+55.86%

Financials

2024 2025
Net sales 398K 281K 243K 228K 208K 391K 26.78M 2.67M 1.05M 13.4M 1.05M 1.03M 44.71M 322K 227K 197K 184K 168K 317K 21.68M 2.16M 847K 10.85M 854K 835K 36.21M
Net income -3.13M -2.21M -1.92M -1.79M -1.64M -3.08M -211M -21.02M -8.24M -106M -8.3M -8.12M -352M -1.45M -1.02M -886K -829K -757K -1.42M -97.49M -9.72M -3.81M -48.8M -3.84M -3.75M -163M
Net Debt -375K -265K -229K -215K -196K -368K -25.23M -2.52M -986K -12.63M -993K -972K -42.13M -25.17K -17.77K -15.4K -14.41K -13.15K -24.75K -1.69M -169K -66.22K -848K -66.71K -65.26K -2.83M
Logo Monto Minerals Ltd
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-